BIAF
bioAffinity·NASDAQ
--
--(--)
--
--(--)
BIAF fundamentals
bioAffinity (BIAF) released its earnings on Aug 14, 2025: revenue was 1.27M (YoY -47.05%), missed estimates; EPS was -5.1 (YoY +10.53%), missed estimates.
Revenue / YoY
1.27M
-47.05%
EPS / YoY
-5.1
+10.53%
Report date
Aug 14, 2025
Earnings
EPS
Revenue
Revenue & Expenses
BIAF has released its 2025 Q4 earnings report, with revenue of 1.59M, reflecting a YoY change of -27.85%, and net profit of -3.14M, showing a YoY change of -5.75%. The Sankey diagram below clearly presents BIAF's revenue sources and cost distribution.
Key Indicators
bioAffinity (BIAF) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
bioAffinity (BIAF)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
bioAffinity (BIAF)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
bioAffinity (BIAF)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does bioAffinity (BIAF) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track bioAffinity (BIAF) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from bioAffinity’s earnings call?What were the key takeaways from bioAffinity's earnings call?Did bioAffinity beat or miss consensus estimates last quarter?What does bioAffinity do and what are its main business segments?What is the revenue and EPS growth rate for bioAffinity year over year?What is bioAffinity's gross profit margin?What guidance did bioAffinity's management provide for the next earnings period?What is the market's earnings forecast for bioAffinity next quarter?
